Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol

Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol

Abstract Background Currently, adjuvant therapy is not recommended for patients with thoracic esophageal squamous cell cancer (TESCC) after radical surgery, and a proportion of these patients go on to develop locoregional recurrence (LRR) within 2 years. Besides, there is no evidence for salvage che...

Full description

Bibliographic Details
Main Authors: Xiao Chang, Lei Deng, Wenjie Ni, Chen Li, Weiming Han, Lin-rui Gao, Shijia Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Nan Bi, Jima Lv, Shugeng Gao, Yousheng Mao, Qi Xue, Zefen Xiao
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Esophageal neoplasm
Locoregional recurrence
R1/R2 resection
Chemoradiation therapy
Palliative management
Online Access:http://link.springer.com/article/10.1186/s12885-020-07315-0

Internet

http://link.springer.com/article/10.1186/s12885-020-07315-0

Similar Items